Recent articles
This Could Be Johnson & Johnson’s Future
As competition heats up for Johnson & Johnson's current blockbuster drugs like Zytiga and Remicade, we have to look into the pipeline to see what the future could hold.
Will Incoming Threats Sink Johnson & Johnson?
J&J is a massive cruise ship in the pharmaceutical industry, but there are plenty of fast-moving sharks skimming around its waters. Which of them do we need to be worried about?
The Johnson & Johnson Numbers You Should Know
Let's take advantage of the calm before the earnings storm to put together your earnings checklist.
The Wall Street Guarantee
Wall Street places its own interests above yours. Why play by its rules?
The Wall Street Guarantee
Wall Street places its own interests above yours. Why play by its rules?
Short Sony Now!
There are many reasons to bet against Sony.
The Motley Fool Goes Green
These days, you can be an Earth-friendly investor and still make money.
The Market Is Turning
The market is turning. Find out how you can take advantage.
Stocks on the Slide
Stocks on the run can be dangerous to follow. But don't go chasing stocks on the slide, either.
How to Boost Your Income
You can augment your existing savings with an income fund.
The Wall Street Guarantee
Wall Street places its own interests above yours. Why play by its rules?
Middleby Soars, but No Splits, Please
Middleby still has room to run.
Find Your Next Double
Don't pass up those doubles while your searching for the next home run stock.
How to Boost Your Income
You can augment your existing savings with an income fund.
The Wall Street Guarantee
Wall Street places its own interests above yours. Why play by its rules?